PEGCETACOPLAN | N217171 | APELLIS PHARMACEUTICALS INC
| Patent # | Expiration | PED | Drug Substance | Drug Product | Use Code | Delist |
|---|---|---|---|---|---|---|
| 7888323 | Dec 4, 2027 | — | Yes | — | — | — |
| 7989589 | Dec 4, 2027 | — | Yes | — | — | — |
| 8168584 | Apr 7, 2027 | — | — | — | — | |
| 9056076 | Oct 25, 2026 | — | — | — | — | |
| 9169307 | Nov 18, 2027 | — | Yes | — | — | |
| 10035822 | Nov 15, 2033 | — | Yes | — | — | — |
| 10125171 | Aug 2, 2033 | — | Yes | — | — | — |
| 10875893 | Nov 15, 2033 | — | Yes | — | — | |
| 11292815 | Nov 15, 2033 | — | Yes | Yes | — | |
| 11661441 | Jan 13, 2033 | — | Yes | — | — | |
| 11903994 | Feb 22, 2037 | — | — | — | — | |
| 12458695 | Dec 14, 2038 | — | — | Yes | — | — |
| 12528836 | Oct 7, 2036 | — | — | — | — |
| Code | Date | Status |
|---|---|---|
| NCE | May 14, 2026 | Expired |
| NP | Feb 22, 2026 | Expired |